Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA)
Novel immune and targeted therapies approved over the past 2 decades have resulted in dramatic improvements in cancer-specific outcomes for many cancer patients. However, many of these agents can induce cardiovascular toxicity in a subset of patients. The field of cardio-oncology was established bas...
Main Authors: | Firas Kreidieh, Jennifer McQuade |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-04-01
|
Series: | American Heart Journal Plus |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S266660222400017X |
Similar Items
-
Clinical aspects of ischemia with no obstructive coronary artery disease (INOCA)
by: Alexander Polyak, et al.
Published: (2024-01-01) -
Clinical and psychological characteristics of patients with ischemia and non-obstructive coronary arteries (INOCA) and obstructive coronary artery disease
by: Dinah L. van Schalkwijk, et al.
Published: (2023-03-01) -
Molecular Hallmarks of Ischemia with Non-Obstructive Coronary Arteries: The “INOCA versus Obstructive CCS” Challenge
by: Alice Bonanni, et al.
Published: (2022-03-01) -
Symptom Presentation among Women with Suspected Ischemia and No Obstructive Coronary Artery Disease (INOCA)
by: Yasmeen K. Taha, et al.
Published: (2023-09-01) -
Evaluation of Ischemia with No Obstructive Coronary Arteries (INOCA) and Contemporary Applications of Cardiac Magnetic Resonance (CMR)
by: Andrew Chang, et al.
Published: (2023-08-01)